000 01492 a2200445 4500
005 20250515015122.0
264 0 _c20060713
008 200607s 0 0 eng d
022 _a0021-9746
024 7 _a10.1136/jcp.2005.030544
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKalpoe, J S
245 0 0 _aRole of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
_h[electronic resource]
260 _bJournal of clinical pathology
_cMay 2006
300 _a537-41 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aCarcinoma
_xtherapy
650 0 4 _aDNA, Viral
_xanalysis
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHerpesvirus 4, Human
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNasopharyngeal Neoplasms
_xtherapy
650 0 4 _aNeoplasm Recurrence, Local
_xvirology
650 0 4 _aPolymerase Chain Reaction
_xmethods
650 0 4 _aRisk
650 0 4 _aSensitivity and Specificity
650 0 4 _aViral Load
700 1 _aDekker, P B Douwes
700 1 _avan Krieken, J H J M
700 1 _aBaatenburg de Jong, R J
700 1 _aKroes, A C M
773 0 _tJournal of clinical pathology
_gvol. 59
_gno. 5
_gp. 537-41
856 4 0 _uhttps://doi.org/10.1136/jcp.2005.030544
_zAvailable from publisher's website
999 _c16100592
_d16100592